Status:
UNKNOWN
Effectiveness of Early Cardiac Rehabilitation
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
65-95 years
Phase:
NA
Brief Summary
The goal of this experimental study is to compare the effects of early (2nd week) cardiac rehabilitation applied in addition to usual care on functional capacity, quality of life, frailty and body com...
Detailed Description
Cardiovascular diseases are still the number one cause of death worldwide, despite significant advances in diagnosis and treatment over the last 50 years. Coronary artery bypass graft (CABG) surgery i...
Eligibility Criteria
Inclusion
- ⩾65 years old patients who underwent CABG surgery in the 2nd week post-op
- No contraindications for exercise training and ability to exercise
- Patients without diagnosed cognitive impairment
Exclusion
- Cardiac arrhythmias that pose a serious risk
- Unstable angina
- Decompensated heart failure
- Unstable blood pressure control
- Peripheral artery disease with claudication
- Severe myocardial ischemia
- Cerebrovascular disease
- Orthopedic disease
- Chronic kidney disease (creatinine \>3.0 mg/dL)
- Liver dysfunction (alanine aminotransferase \>200 U/L)
- Other serious organ failure and/or other medical causes (e.g. difficulty walking)
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06116773
Start Date
December 1 2023
End Date
December 1 2025
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Basaksehir Cam and Sakura City Hospital
Istanbul, Turkey (Türkiye), 34480